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THU0600 A CASE OF SYSTEMIC SCLEROSIS COMPLICATED 
BY RENAL CRISIS: POTENTIAL ETIOPATHOGENETIC 
ROLE OF CYTOMEGALOVIRUS AND TREATMENT
A. Palermo1, E. Galli1, A. Spinella1, E. Cocchiara1, F. Lumetti1, G. Klinowski1, 
S. Giovanella2, C. U. Manzini1, C. Salvarani1, D. Giuggioli1. 1Scleroderma Unit, 
Chair of Rheumatology, University of Modena and Reggio Emilia, Modena, Italy; 
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Background: Scleroderma renal crisis (SRC) is a rare complication of systemic 
sclerosis (SSc), which can be triggered by viruses, such as Cytomegalovirus 
(CMV). SRC presents as a new-onset accelerated-phase hypertension with/with-
out rapidly progressive renal failure.
Objectives: Here we describe the case of a patient developing SSc compli-
cated by the appearance of SRC after a recent episode of acute Cytomegalovirus 
infection.
Methods: A 66-year-old male was referred to our Scleroderma Unit in March 
2019. He presented with widespread skin rash, exertional dyspnoea and 
peripheral oedemas. He reported a myocarditis due to CMV occurred in Octo-
ber 2018. Antibodies anti-CMV IgM were detected in his serum. The patient 
developed a progressive cutaneous involvement characterized by diffuse 
oedema, sclerosis and melanoderma. Subsequently, Raynaud’s phenome-
non, puffy hands and pitting scars occurred. Laboratory tests showed positive 
ANA in a titer of 1:640 in a nucleolar staining pattern. Additionally, persis-
tence of anti-CMV IgM was found. Skin biopsy showed scleroderma-like 
finding. Nailfold capillaroscopy revealed a SSc pattern. Chest high resolution 
computed tomography displayed basal interstitial thickening and subpleuric 
ground-glass opacities. Therefore, the patient was diagnosed with SSc. Three 
weeks later he developed severe hypertension and a rapid, progressive renal 
impairment. Serum creatinine increased (up to 4.15 mg/dl), glomerular fil-
tration rate impaired (25 ml/min). Renal biopsy (picture A, B) revealed acute 
thrombotic microangiopathy. A diagnosis of thrombotic thrombocytopenic pur-
pura was excluded. The patient was diagnosed with SRC and we started ther-
apy with ACE-inhibitor and loop diuretic. Even if the dosage of ACE-inhibitor 
was increased up to the maximum tolerate dose, his renal function did not 
improve and the blood pressure control was inadequate. Consequently, the 
patient underwent plasma exchange (PEx) sessions. Two weeks later there 
was an improvement of renal function and blood pressure normalized. Six 
months later the disease was controlled: glomerular filtration rate was 41 ml/
min and blood pressure was within the normal range. The patient was treated 
with ACE-inhibitor and underwent fortnightly apheretic sessions. Treatment 
for scleroderma vasculopathy is ongoing.
Results: Viral infections may be responsible for SSc. A brief interval 
between an acute viral infection and the onset of SSc may suggest CMV as 
a possible trigger for the disease. Similarly, other infectious agents could 
be involved in the multistep and multifactorial mechanism of SSc. This case 
sheds light on the potential and intriguing role of CMV in SSc. Moreover, it 
leads us to hypothesize a CMV possible direct role in sclerodermal kidney 
damage. Use of ACE-inhibitor significantly reduced the mortality rate due 
to this complication. Exact therapeutic mechanism of PEx in the treatment 
of SSc is unclear.
Conclusion: In our case the integrated ACE-inhibitor-PEx approach has showed 
effectiveness and safety in the management of SRC.
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Background: Eosinophilic Granulomatosis with Polyangiitis (EGPA) is an 
ANCA-associated vasculitis, characterized by eosinophilic infiltration in tis-
sues, intravascular and extravascular granuloma formation. It is a rare dis-
ease, affecting between 0 and 4 per million population per year. The cardiac 
involvement occurs in 15-60% of EGPA patients (generally ANCA-negative); 
it is often insidious, underestimated and it has a poor prognosis. The dis-
ease usually shows a prodromal phase characterized by asthma and allergic 
manifestations.
Objectives: We report the case of a young patient with acute coronary syndrome 
(ACS) complicated by cardiogenic shock as the first manifestation of EGPA.
Methods: A 36 year old Indian male patient, with a previous history of asthma, 
rhinitis, Raynaud syndrome and allergy to ketoprofen, presented to the emer-
gency department with a complaint of chest pain and dyspnea. Cardiac troponin 
was elevated and he was admitted to intensive care unit with a diagnosis of 
ACS. The patient conditions rapidly deteriorated due to acute cardiogenic shock 
and an urgent coronary angiogram was performed. An occlusion of the left 
main coronary artery was treated with angioplasty and two drug-eluting stents. 
Echocardiography showed severe left ventricular dysfunction requiring inotropic 
and intra-aortic balloon pump support. A mild dermatitis after salicylic acid 
administration resolved with intravenous hydrocortisone 1 g. The thrombophilia 
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